Skye Bioscience (SKYE) PT Lowered to $14 at Craig-Hallum
Tweet
Share
E-mailGet Alerts SKYE Hot Sheet
Price: $0.50 -7.41%
Rating Summary:
5 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
5 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Craig-Hallum analyst Albert Lowe lowered the price target on Skye Bioscience (NASDAQ: SKYE) to $14.00 (from $18.00) while maintaining a Buy rating.
You May Also Be Interested In
- Skye Bioscience and Redx Pharma Announce Transaction Agreement and $125 Million in Financings
- Honasa Consumer Ltd (HONASA:IN) PT Raised to INR720 at ICICI Securities
- Calian Group Ltd (CGY:CN) (CLNFF) PT Raised to Cdn$109 at Desjardins
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
